| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | Director | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK | /s/ Carl L. Gordon, Member of OrbiMed Advisors LLC | 18 Dec 2025 | 0001055951 |
| OrbiMed Capital GP VII LLC | Director | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK | /s/ Carl L. Gordon, Member of OrbiMed Capital GP VII LLC | 18 Dec 2025 | 0001760648 |
| OrbiMed Genesis GP LLC | Director | 601 LEXINGTON AVENUE, 54TH FLOOR, NEW YORK | /s/ Carl L. Gordon, Member of OrbiMed Genesis GP LLC | 18 Dec 2025 | 0001808744 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | KROS | Common Stock | Disposed to Issuer | $2,486,012 | -140,057 | -16% | $17.75 | 759,155 | 21 Nov 2025 | See footnotes | F1, F2, F4 |
| transaction | KROS | Common Stock | Disposed to Issuer | $1,321,754 | -74,465 | -62% | $17.75 | 45,057 | 21 Nov 2025 | See footnotes | F1, F3, F4 |
| Id | Content |
|---|---|
| F1 | Disposed of in connection with the Issuer's completion of a cash tender offer. |
| F2 | These securities are held of record by OrbiMed Private Investments VII, LP ("OPI VII"). OrbiMed Capital GP VII LLC ("OrbiMed GP") is the general partner of OPI VII and OrbiMed Advisors LLC ("OrbiMed Advisors") is the managing member of OrbiMed GP. By virtue of such relationships, OrbiMed GP and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by OPI VII and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by OPI VII. |
| F3 | These securities are held of record by OrbiMed Genesis Master Fund, L.P. ("Genesis"). OrbiMed Genesis GP LLC ("Genesis GP") is the general partner of Genesis and OrbiMed Advisors is the managing member of Genesis GP. By virtue of such relationships, Genesis GP and OrbiMed Advisors may be deemed to have voting power and investment power over the securities held by Genesis and as a result, may be deemed to have beneficial ownership over such securities. OrbiMed Advisors exercises voting and investment power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the shares held by Genesis. |
| F4 | This report on Form 4 is jointly filed by OrbiMed Advisors, OrbiMed GP, and Genesis GP. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated a representative, Carl L. Gordon, a member of OrbiMed Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose. |